Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Accumulated Expenses: 2017-2018

Historic Other Accumulated Expenses for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $109,000.

  • Astria Therapeutics' Other Accumulated Expenses fell 69.54% to $106,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $106,000, marking a year-over-year decrease of 69.54%. This contributed to the annual value of $109,000 for FY2018, which is 67.17% down from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Other Accumulated Expenses is $109,000, which was down 67.17% from $332,000 recorded in FY2017.
  • Astria Therapeutics' Other Accumulated Expenses' 5-year high stood at $332,000 during FY2017, with a 5-year trough of $109,000 in FY2018.
  • Moreover, its 2-year median value for Other Accumulated Expenses was $220,500 (2017), whereas its average is $220,500.
  • Data for Astria Therapeutics' Other Accumulated Expenses shows a maximum YoY slumped of 67.17% (in 2018) over the last 5 years.
  • Astria Therapeutics' Other Accumulated Expenses (Yearly) stood at $332,000 in 2017, then slumped by 67.17% to $109,000 in 2018.